Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.47 |
| ▸ | ANPEP | P15144 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PEPD | P12955 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30686137 | 1.00 | MMP2 (0.47) | MMP2ANPEPTSHRALDH1A1BRD4 | |
| SCHEMBL19899277 | 0.82 | MMP2 (0.49) | MMP2ANPEPTSHRALDH1A1POLB | |
| SCHEMBL1833567 | 0.82 | MMP2 (0.41) | MMP2ANPEPTSHRALDH1A1POLB | |
| SCHEMBL996114 | 0.82 | ALDH1A1 (0.59) | MMP2ANPEPALDH1A1KMT2APEPD | |
| SCHEMBL10061040 | 0.82 | ALDH1A1 (0.59) | MMP2ANPEPALDH1A1KMT2APEPD | |
| SCHEMBL996111 | 0.82 | ALDH1A1 (0.59) | MMP2ANPEPALDH1A1KMT2APEPD | |
| SCHEMBL996113 | 0.82 | ALDH1A1 (0.59) | MMP2ANPEPALDH1A1KMT2APEPD | |
| SCHEMBL993099 | 0.82 | MMP2 (0.67) | MMP2ANPEPTSHRALDH1A1BRD4 | |
| SCHEMBL542252 | 0.82 | MMP2 (0.67) | MMP2ANPEPTSHRALDH1A1BRD4 | |
| SCHEMBL542253 | 0.82 | MMP2 (0.67) | MMP2ANPEPTSHRALDH1A1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021243273-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | TAXIS PHARMACEUTICALS, INC. (US) | 2021-12-02 | — | — | WO | disclosed |
| CN-111148739-A | Cyclopeptide antibiotics | 豪夫迈·罗氏有限公司 | 2020-05-12 | — | — | CN | disclosed |
| EP-3204403-A1 | IMMUNOMODULATORS | Bristol-Myers Squibb Company (US) | 2017-08-16 | — | — | EP | disclosed |
| WO-2017116949-A1 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2017-07-06 | — | — | WO | disclosed |
| EP-3157909-A1 | LMP7 INHIBITORS | Principia Biopharma Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| EP-3052491-A1 | USE OF MACROCYLIC PICOLINAMIDES AS FUNGICIDES | Dow AgroSciences LLC (US) | 2016-08-10 | — | — | EP | disclosed |
| EP-3052490-A1 | MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | Dow AgroSciences LLC (US) | 2016-08-10 | — | — | EP | disclosed |
| WO-2016057624-A1 | IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-04-14 | — | — | WO | disclosed |
| WO-2015195950-A1 | LMP7 INHIBITORS | PRINCIPIA BIOPHAMRAM INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| EP-2948461-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Entasis Therapeutics Limited (GB) | 2015-12-02 | — | — | EP | disclosed |
| WO-2015050819-A1 | USE OF MACROCYLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2015-04-09 | — | — | WO | disclosed |
| WO-2015050818-A1 | MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | DOW AGROSCIENCES LLC (US) | 2015-04-09 | — | — | WO | disclosed |
| EP-2847185-A2 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | Dow AgroSciences LLC (US) | 2015-03-18 | — | — | EP | disclosed |
| WO-2014114929-A1 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | ASTRAZENECA AB (SE) | 2014-07-31 | — | — | WO | disclosed |
| WO-2013169662-A2 | MACROCYCLIC PICOLINAMIDES AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2013-11-14 | — | — | WO | disclosed |
| EP-2585447-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | Vertex Pharmaceuticals Incorporated (US) | 2013-05-01 | — | — | EP | disclosed |
| WO-2012006055-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-01-12 | — | — | WO | disclosed |
| WO-2010091164-A1 | INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE | EXELIXIS, INC. (US) | 2010-08-12 | — | — | WO | disclosed |
| EP-2142519-A1 | DPP-IV INHIBITOR INCLUDING BETA-AMINO GROUP, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR PREVENTING AND TREATING A DIABETES OR AN OBESITY | Dong-A Pharm.Co., Ltd. (KR) | 2010-01-13 | — | — | EP | disclosed |
| WO-2008130151-A1 | DPP-IV INHIBITOR INCLUDING BETA-AMINO GROUP, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR PREVENTING AND TREATING A DIABETES OR AN OBESITY | DONG-A PHARM. CO., LTD. (KR) | 2008-10-30 | — | — | WO | disclosed |